Browsed by
Category: Intellectual Property

Science policy weekly roundup: August 31, 2018 ?>

Science policy weekly roundup: August 31, 2018

Senate committee holds hearing on nomination of Kelvin Droegemeier to head OSTP Science Policy Analyst André Porter discusses last week’s U.S. Senate committee hearing to nominate Kelvin Droegemeier to lead the Office of Science and Technology Policy. Several senators asked the nominee about how he would ensure that scientific evidence would be taken seriously by the administration. Droegemeier, a meteorologist, also side-stepped questions regarding whether humans were responsible for climate change. Read more here.   Elizabeth Warren raises concern about…

Read More Read More

Science policy weekly roundup: August 24, 2018 ?>

Science policy weekly roundup: August 24, 2018

  What do you think about NIH efforts to support next generation of researchers? The National Institutes of Health is proposing recommendations to support the next generation of researchers, and we at the American Society for Biochemistry and Molecular Biology want to know what you think. We will collect your feedback and send it to the NIH. Submit your opinion and view a timeline of the ASBMB’s involvement here. U.S. Senate passes NIH appropriations bill In an 85-7 vote on…

Read More Read More

UPDATE: Broad Institute claims victory in CRISPR intellectual property case ?>

UPDATE: Broad Institute claims victory in CRISPR intellectual property case

Previously we reported on the ongoing battle for intellectual property patent ownership of the CRISPR gene-editing technology between the University of California at Berkeley and the Broad Institute of the Massachusetts Institute of Technology and Harvard University. In this case, UC Berkeley challenged multiple patents filed by the Broad Institute on the grounds that they overlapped or interfered with existing patents held by UC Berkeley. On Feb 15, the U.S. Patent and Trademark Office court ruled in favor of the…

Read More Read More

Who owns the CRISPR gene editing method? ?>

Who owns the CRISPR gene editing method?

On December 6, the U.S. Patent and Trademark Office began hearing arguments from The University of California, Berkeley and the Broad Institute, a joint collaborative effort between the Massachusetts Institute of Technology and Harvard University, regarding the intellectual property ownership of the gene editing method known as the CRISPR/Cas system. UC Berkeley was the first to file a patent for this method, while the Broad Institute has previously won multiple awards regarding its research on this system and has filed…

Read More Read More